I-Mab（IMAB）の財務IMABI-Mab

Evaluating the bottom line, I-Mab maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -18.46%, provide a clear picture of how effectively IMAB converts its operational activities into shareholder value.

In the context of the broader market, IMAB competes directly with industry leaders such as VNDA and ACIU. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, IMAB's gross margin of N/A stands against VNDA's 89.02% and ACIU's 100.00%. Such benchmarking helps identify whether I-Mab is trading at a premium or discount relative to its financial performance.